Opinion: Think Like Turing

Biomedical researchers would benefit from emulating the logically rigorous reasoning of the late Alan Turing, British mathematician, computer scientist, and master cryptographer.

Written byNeil Greenspan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A slate statue of Alan Turing in slate at Bletchley Park. The photograph on the wall in the background is also of Turing. Wikimedia, Jon CallasDuring World War II, Alan Turing and his Bletchley Park colleagues devoted countless hours to using rigorous deductive reasoning to decipher the military code associated with the Enigma machine. Their eventual success in cracking the German code allowed the Allies to eavesdrop on Nazi military communications, thereby changing the course of the war.

If they explicitly think about types of reasoning at all, biomedical scientists may subscribe to the view that deductive logic is primarily of value in mathematics. In this centenary year of his birth, it is appropriate to reflect on Turing’s profound and influential contributions, often dominated by deductive reasoning, not only to mathematical logic, but also to cryptography, computer science, and theoretical biology—and their relevance to the biomedical research enterprise.

Deductive logic is reasoning such that valid logical transformations applied to true premises guarantee the truth of any derived conclusions. For example, if all biomedical scientists are mortal, and Li is a biomedical scientist, then Li must be mortal. This form of argument contrasts with, for example, inductive reasoning, for which true assumptions and properly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies